<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320311434240</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320311434240</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to vasculitis: a meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Lee</surname><given-names>Young Ho</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Choi</surname><given-names>Sung Jae</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Ji</surname><given-names>Jong Dae</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname><given-names>Gwan Gyu</given-names></name>
</contrib>
<aff id="aff1-1470320311434240">Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-1470320311434240">Young Ho Lee, Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1, Anam-dong 5-ga, Seongbuk-gu, Seoul 136-705, Korea. Email: <email>lyhcgh@korea.ac.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<fpage>196</fpage>
<lpage>201</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p><italic>Introduction</italic>: To explore whether the insertion (I) and deletion (D) polymorphism of angiotensin-converting enzyme (<italic>ACE</italic>) confers susceptibility to vasculitis.</p>
<p><italic>Materials and methods</italic>: A meta-analysis was conducted on the associations between the ACE I/D polymorphism and vasculitis.</p>
<p><italic>Results</italic>: Twelve studies, including four on Behçet’s disease (BD), four on Henoch–Schenlein purpura (HSP), three on Kawasaki disease (KD), and one on Wegener’s granulomatosis, were available for the meta-analysis. Meta-analysis showed that the DD + ID genotype was associated with susceptibility to vasculitis (odds ratio [OR] 1.468, 95% confidence interval [CI] 1.214–1.468, <italic>p</italic> = 7.4 × 10<sup>−5</sup>). The overall OR for the D allele was significantly increased in BD (OR 1.313, 95% CI 1.017–1.695). Meta-analysis of the DD+ID genotype, the DD genotype and the DD vs. II genotype showed marginal associations with BD, but meta-analysis of the D allele, and the DD+ID genotype showed significant associations with HSP (OR 1.446, 95% CI 1.021–2.049, <italic>p</italic> = 0.038; OR 1.881, 95% CI 1.385–2.595, <italic>p</italic> = 6.6 × 10<sup>−5</sup>). On the other hand, meta-analysis showed no association between KD and the <italic>ACE</italic> I/D polymorphism.</p>
<p><italic>Conclusions</italic>: This meta-analysis shows that the <italic>ACE</italic> I/D polymorphism is associated with vasculitis susceptibility, especially in BD and HSP.</p>
</abstract>
<kwd-group>
<kwd>Angiotensin-converting enzyme</kwd>
<kwd>meta-analysis</kwd>
<kwd>polymorphism</kwd>
<kwd>vasculitis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1470320311434240" sec-type="intro">
<title>Introduction</title>
<p>Vasculitis is a heterogeneous group of disorders characterized by inflammation and damage in blood vessels, leading to tissue or organ injury.<sup><xref ref-type="bibr" rid="bibr1-1470320311434240">1</xref></sup> Although the etiology of vasculitis is not fully understood, it has been suggested to occur given suitable interactions between a susceptible genetic background and environmental factors.</p>
<p>Angiotensin-converting enzyme (ACE) activates angiotensin I into angiotensin II and inactivates bradykinin via the kallikrein–kininogen system.<sup><xref ref-type="bibr" rid="bibr2-1470320311434240">2</xref></sup> Angiotensin II is the main effector molecule of the renin–angiotensin system (RAS) and it is pleiotropic and a mediator of the development and progression of renal disease.<sup><xref ref-type="bibr" rid="bibr3-1470320311434240">3</xref></sup> Furthermore, angiotensin II is a potent pro-inflammatory modulator that augments and perpetuates immune responses.<sup><xref ref-type="bibr" rid="bibr3-1470320311434240">3</xref></sup> The <italic>ACE</italic> gene, located on chromosome 17q23, contains an insertion (I) /deletion (D) polymorphism within intron 16 that involves the presence or absence of a 287 bp repeat sequence.<sup><xref ref-type="bibr" rid="bibr4-1470320311434240">4</xref></sup> The DD genotype is associated with about 2-fold higher tissue and plasma concentrations of ACE than the II genotype,<sup><xref ref-type="bibr" rid="bibr4-1470320311434240">4</xref></sup> and thus it seems possible that the D allele could play a role in the pathogenesis of vasculitis.</p>
<p>The <italic>ACE</italic> I/D polymorphism has been studied in the context of vasculitis.<sup><xref ref-type="bibr" rid="bibr5-1470320311434240">5</xref>–<xref ref-type="bibr" rid="bibr16-1470320311434240">16</xref></sup> However, published genetic association results for the <italic>ACE</italic> I/D polymorphism are controversial and inconclusive,<sup><xref ref-type="bibr" rid="bibr5-1470320311434240">5</xref>–<xref ref-type="bibr" rid="bibr16-1470320311434240">16</xref></sup> which may be due to small sample sizes, low statistical power, and/or clinical heterogeneity. Therefore, in order to overcome the limitations of individual studies, resolve inconsistencies, and reduce the likelihood that random errors are responsible for false-positive or false-negative associations,<sup><xref ref-type="bibr" rid="bibr17-1470320311434240">17</xref></sup> we turned to meta-analysis. In the present study, we investigated whether the <italic>ACE</italic> I/D polymorphism contributes to vasculitis susceptibility using a meta-analysis approach.</p>
</sec>
<sec id="section2-1470320311434240" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-1470320311434240">
<title>Identification of eligible studies and data extraction</title>
<p>A literature search was conducted for studies that examined associations between the <italic>ACE</italic> I/D polymorphism and vasculitis. We utilized the MEDLINE citation index to identify articles in which the <italic>ACE</italic> I/D polymorphism was determined in vasculitis patients and controls (up to June 2011). In addition, all references mentioned in identified articles were reviewed to identify studies not indexed by MEDLINE. The following key words and subject terms were searched, ‘angiotensin-converting enzyme’, ’<italic>ACE</italic>’, and ‘vasculitis’, and the following information was extracted from each identified study: author, year of publication, ethnicity of the study population, demographics, numbers of cases and controls, and the frequencies of the genotypes and alleles of the <italic>ACE</italic> I/D polymorphism.</p>
</sec>
<sec id="section4-1470320311434240">
<title>Evaluation of publication bias and study quality</title>
<p>Funnel plots are used to detect publication bias, but they require a range of studies of varying sizes and subjective judgments, and thus, we evaluated publication bias using Egger’s linear regression test,<sup><xref ref-type="bibr" rid="bibr18-1470320311434240">18</xref></sup> which measures funnel plot asymmetry on a natural logarithm scale of odds ratios (ORs). The chi-square test was used to determine if observed genotype frequencies in controls conformed to Hardy–Weinberg (H–W) expectations.</p>
</sec>
<sec id="section5-1470320311434240">
<title>Evaluation of statistical associations</title>
<p>We performed meta-analyses using: (i) the allelic contrast (D vs. I), (ii) the recessive (DD vs. ID + II), (iii) the dominant (DD + ID vs. II), and (iv) the additive models (DD vs. II). Point estimates of risks, ORs, and 95% confidence intervals (CIs) were estimated for each study. In addition, within- and between-study variations and heterogeneities were assessed using Cochran’s <italic>Q</italic>-statistic. This heterogeneity test assesses the null hypothesis that all studies evaluated the same effect. The effect of heterogeneity was quantified using <italic>I</italic><sup>2</sup>, which ranges between 0 and 100% and represents the proportion of between-study variability attributable to heterogeneity rather than chance.<sup><xref ref-type="bibr" rid="bibr19-1470320311434240">19</xref></sup> <italic>I</italic><sup>2</sup> values of 25%, 50%, and 75% were nominally assigned as low, moderate, and high estimates. The fixed effects model assumes that a genetic factor has a similar effect on vasculitis susceptibility across all studies investigated, and that observed variations among studies are caused by chance alone.<sup><xref ref-type="bibr" rid="bibr20-1470320311434240">20</xref></sup> The random effects model assumes that different studies show substantial diversity and assesses both within-study sampling error and between-study variance.<sup><xref ref-type="bibr" rid="bibr21-1470320311434240">21</xref></sup> When study groups are homogeneous, the two models are similar, but if this is not the case the random effects model usually provides wider CIs than the fixed effects model. The random effects model is best used in the presence of significant between-study heterogeneity.<sup><xref ref-type="bibr" rid="bibr21-1470320311434240">21</xref></sup> Statistical manipulations were undertaken using a Comprehensive Meta-Analysis computer program (Biosta, Englewood, NJ, USA). The power of each study was computed as the probability of detecting an association between the ACE polymorphism and vasculitis using a significance level of 0.05, assuming an OR of 1.5 (small effect size). Power analysis was performed using the statistical program G*Power (<ext-link ext-link-type="uri" xlink:href="http://www.psycho.uni-duesseldorf.de/aap/projects/gpower">http://www.psycho.uni-duesseldorf.de/aap/projects/gpower</ext-link>).</p>
</sec></sec>
<sec id="section6-1470320311434240" sec-type="results">
<title>Results</title>
<sec id="section7-1470320311434240">
<title>Studies included in the meta-analysis</title>
<p>Twenty-four studies were identified by electronic and manual searches and 15 were selected for a full-text review based on title and abstract details.<sup><xref ref-type="bibr" rid="bibr5-1470320311434240">5</xref>–<xref ref-type="bibr" rid="bibr16-1470320311434240">16</xref>,<xref ref-type="bibr" rid="bibr22-1470320311434240">22</xref>–<xref ref-type="bibr" rid="bibr24-1470320311434240">24</xref></sup> Three studies were excluded because they did not investigate healthy controls.<sup><xref ref-type="bibr" rid="bibr22-1470320311434240">22</xref>–<xref ref-type="bibr" rid="bibr24-1470320311434240">24</xref></sup> Thus, 12 studies met the inclusion criteria.<sup><xref ref-type="bibr" rid="bibr5-1470320311434240">5</xref>–<xref ref-type="bibr" rid="bibr16-1470320311434240">16</xref></sup> These studies comprised four on Behçet’s disease (BD), four on Henoch–Schenlein purpura (HSP), three on Kawasaki disease (KD), and one Wegener’s granulomatosis (WG). They consisted of six Asian, four Turkish, and two European studies, and in total, they included 1184 cases and 1464 controls. Selected details of the individual studies are summarized in <xref ref-type="table" rid="table1-1470320311434240">Table 1</xref>. The statistical powers of these 12 studies ranged from 16.7% to 53.6%. None of the studies had a statistical power exceeding 80%.</p>
<table-wrap id="table1-1470320311434240" position="float">
<label>Table 1.</label>
<caption>
<p>Details of the individual studies included in the meta-analysis</p>
</caption>
<graphic alternate-form-of="table1-1470320311434240" xlink:href="10.1177_1470320311434240-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Author and reference</th>
<th align="left">Year</th>
<th align="left">Country (ethnicity)</th>
<th align="left">Disease</th>
<th align="left" colspan="2">Numbers</th>
<th align="left" colspan="2">D-allele</th>
<th align="left" colspan="4">Association</th>
<th align="left">HWE <italic>p</italic>-value</th>
<th align="left">Power<xref ref-type="table-fn" rid="table-fn1-1470320311434240">*</xref> (%)</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th align="left">Cases</th>
<th align="left">Controls</th>
<th align="left">Cases</th>
<th align="left">Controls</th>
<th align="left">OR</th>
<th align="left" colspan="2">95% CI</th>
<th align="left"><italic>p</italic>-value</th>
<th/>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>Liu<sup><xref ref-type="bibr" rid="bibr5-1470320311434240">5</xref></sup></td>
<td>2010</td>
<td>China</td>
<td>HSP</td>
<td>140</td>
<td>217</td>
<td>43.2</td>
<td>33.2</td>
<td>1.533</td>
<td>1.125</td>
<td>2.089</td>
<td>0.007</td>
<td>0.444</td>
<td>47.1</td>
</tr>
<tr>
<td>Dursun<sup><xref ref-type="bibr" rid="bibr6-1470320311434240">6</xref></sup></td>
<td>2009</td>
<td>Turkey</td>
<td>BD</td>
<td>73</td>
<td>90</td>
<td>63.7</td>
<td>55.0</td>
<td>1.436</td>
<td>0.918</td>
<td>2.245</td>
<td>0.113</td>
<td>0.054</td>
<td>24.7</td>
</tr>
<tr>
<td>Shim<sup><xref ref-type="bibr" rid="bibr7-1470320311434240">7</xref></sup></td>
<td>2006</td>
<td>Korea</td>
<td>KD</td>
<td>55</td>
<td>43</td>
<td>42.7</td>
<td>57.0</td>
<td>0.563</td>
<td>0.319</td>
<td>0.996</td>
<td>0.048</td>
<td>0.013</td>
<td>16.7</td>
</tr>
<tr>
<td>Ozakaya<sup><xref ref-type="bibr" rid="bibr8-1470320311434240">8</xref></sup></td>
<td>2006</td>
<td>Turkey</td>
<td>HSP</td>
<td>114</td>
<td>164</td>
<td>54.4</td>
<td>47.3</td>
<td>1.331</td>
<td>0.948</td>
<td>1.868</td>
<td>0.098</td>
<td>3.4×10<sup>−8</sup></td>
<td>38.5</td>
</tr>
<tr>
<td>Turgut<sup><xref ref-type="bibr" rid="bibr9-1470320311434240">9</xref></sup></td>
<td>2005</td>
<td>Turkey</td>
<td>BD</td>
<td>35</td>
<td>150</td>
<td>84.3</td>
<td>72.7</td>
<td>2.018</td>
<td>1.010</td>
<td>4.030</td>
<td>0.047</td>
<td>0.001</td>
<td>27.4</td>
</tr>
<tr>
<td>Ozturk<sup><xref ref-type="bibr" rid="bibr10-1470320311434240">10</xref></sup></td>
<td>2004</td>
<td>Turkey</td>
<td>BD</td>
<td>90</td>
<td>30</td>
<td>55.6</td>
<td>56.7</td>
<td>0.956</td>
<td>0.530</td>
<td>1.723</td>
<td>0.881</td>
<td>1.0</td>
<td>19.4</td>
</tr>
<tr>
<td>Chang<sup><xref ref-type="bibr" rid="bibr11-1470320311434240">11</xref></sup></td>
<td>2004</td>
<td>Korea</td>
<td>BD</td>
<td>70</td>
<td>106</td>
<td>44.3</td>
<td>39.6</td>
<td>1.211</td>
<td>0.786</td>
<td>1.866</td>
<td>0.385</td>
<td>0.21</td>
<td>26.3</td>
</tr>
<tr>
<td>Fuzakawa<sup><xref ref-type="bibr" rid="bibr12-1470320311434240">12</xref></sup></td>
<td>2004</td>
<td>Japan</td>
<td>KD</td>
<td>276</td>
<td>145</td>
<td>34.8</td>
<td>31.4</td>
<td>1.166</td>
<td>0.861</td>
<td>1.580</td>
<td>0.321</td>
<td>0.444</td>
<td>53.6</td>
</tr>
<tr>
<td>Wu<sup><xref ref-type="bibr" rid="bibr13-1470320311434240">13</xref></sup></td>
<td>2004</td>
<td>China</td>
<td>KD</td>
<td>107</td>
<td>107</td>
<td>38.8</td>
<td>41.1</td>
<td>0.907</td>
<td>0.616</td>
<td>1.336</td>
<td>0.622</td>
<td>1.0</td>
<td>30.9</td>
</tr>
<tr>
<td>Zhou<sup><xref ref-type="bibr" rid="bibr14-1470320311434240">14</xref></sup></td>
<td>2004</td>
<td>China</td>
<td>HSP</td>
<td>103</td>
<td>100</td>
<td>44.7</td>
<td>25.5</td>
<td>2.358</td>
<td>1.549</td>
<td>3.589</td>
<td>0.000</td>
<td>1.0</td>
<td>29.6</td>
</tr>
<tr>
<td>Murakozy<sup><xref ref-type="bibr" rid="bibr15-1470320311434240">15</xref></sup></td>
<td>2001</td>
<td>Germany</td>
<td>WG</td>
<td>39</td>
<td>262</td>
<td>55.1</td>
<td>54.0</td>
<td>1.046</td>
<td>0.649</td>
<td>1.688</td>
<td>0.853</td>
<td>1.0</td>
<td>41.1</td>
</tr>
<tr>
<td>Amoroso<sup><xref ref-type="bibr" rid="bibr16-1470320311434240">16</xref></sup></td>
<td>1998</td>
<td>Italy</td>
<td>HSP</td>
<td>82</td>
<td>50</td>
<td>57.9</td>
<td>62.0</td>
<td>0.844</td>
<td>0.507</td>
<td>1.404</td>
<td>0.513</td>
<td>0.365</td>
<td>20.9</td>
</tr>
<tr>
<td>Total</td>
<td/>
<td/>
<td/>
<td>1184</td>
<td>1464</td>
<td>51.6</td>
<td>47.9</td>
<td>1.211</td>
<td>0.997</td>
<td>1.471</td>
<td>0.053</td>
<td/>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320311434240">
<p>HSP: Henoch–Schonlein purpura, BD: Behçet’s disease, KD: Kawasaki disease, WG: Wegener’s granulomatosis, OR: odds ratio, CI: confidence interval, HWE: Hardy–Weinberg equilibrium. * Power calculations assume α = 0.05, OR = 1.5.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-1470320311434240">
<title>Meta-analysis of the association between the <italic>ACE</italic> I/D polymorphism and vasculitis</title>
<p>Meta-analysis was performed on all vasculitis patients and on patients with BD, HSP, or KD. A summary of the meta-analysis findings of the relation between the <italic>ACE</italic> I/D polymorphism and vasculitis is provided in <xref ref-type="table" rid="table1-1470320311434240">Table 1</xref>. Meta-analysis revealed a non-significant association between the D allele and vasculitis (OR 1.211, 95% CI 0.997–1.471, <italic>p</italic> = 0.053) (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>), and meta-analysis of the <italic>ACE</italic> I/D polymorphism showed that the DD + ID genotype (dominant effect) was associated with susceptibility to vasculitis (OR 1.468, 95% CI 1.214–1.468, <italic>p</italic> = 7.4 × 10<sup>−5</sup>) (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>, <xref ref-type="fig" rid="fig1-1470320311434240">Figure 1</xref>).</p>
<table-wrap id="table2-1470320311434240" position="float">
<label>Table 2.</label>
<caption>
<p>Meta-analysis of the association between the ACE I/D polymorphism and vasculitis</p>
</caption>
<graphic alternate-form-of="table2-1470320311434240" xlink:href="10.1177_1470320311434240-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Disease</th>
<th align="left">Comparison</th>
<th align="left">No. of studies</th>
<th align="left" colspan="3">Test of association</th>
<th align="left" colspan="3">Test of heterogeneity</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th align="left">OR</th>
<th align="left">95% CI</th>
<th align="left"><italic>p</italic>-value</th>
<th align="left">Model</th>
<th align="left"><italic>p</italic>-value</th>
<th align="left"><italic>I</italic><sup>2</sup></th>
</tr>
</thead>
<tbody>
<tr>
<td>Vasculitis</td>
<td>D vs. I</td>
<td>12</td>
<td>1.211</td>
<td>0.997–1.471</td>
<td>0.053</td>
<td>R</td>
<td>0.005</td>
<td>58.8</td>
</tr>
<tr>
<td/>
<td>DD + ID vs. II</td>
<td>12</td>
<td>1.468</td>
<td>1.214–1.775</td>
<td>7.4×10<sup>−5</sup></td>
<td>F</td>
<td>0.803</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD vs. ID + II</td>
<td>12</td>
<td>1.106</td>
<td>0.706–1.732</td>
<td>0.660</td>
<td>R</td>
<td>0.000</td>
<td>75.2</td>
</tr>
<tr>
<td/>
<td>DD vs. II</td>
<td>12</td>
<td>1.514</td>
<td>0.963–2.378</td>
<td>0.072</td>
<td>R</td>
<td>0.003</td>
<td>61.4</td>
</tr>
<tr>
<td>BD</td>
<td>D vs. I</td>
<td>4</td>
<td>1.313</td>
<td>1.017–1.695</td>
<td>0.037</td>
<td>F</td>
<td>0.410</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD + ID vs. II</td>
<td>4</td>
<td>1.428</td>
<td>0.929–2.194</td>
<td>0.104</td>
<td>F</td>
<td>0.780</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD vs. ID + II</td>
<td>4</td>
<td>1.371</td>
<td>0.940–2.000</td>
<td>0.101</td>
<td>F</td>
<td>0.450</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD vs. II</td>
<td>4</td>
<td>1.624</td>
<td>0.979–2.693</td>
<td>0.060</td>
<td>F</td>
<td>0.740</td>
<td>0</td>
</tr>
<tr>
<td>HSP</td>
<td>D vs. I</td>
<td>4</td>
<td>1.446</td>
<td>1.021–2.049</td>
<td>0.038</td>
<td>R</td>
<td>0.020</td>
<td>69.4</td>
</tr>
<tr>
<td/>
<td>DD + ID vs. II</td>
<td>4</td>
<td>1.881</td>
<td>1.385–2.595</td>
<td>6.6×10<sup>−4</sup></td>
<td>F</td>
<td>0.816</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD vs. ID + II</td>
<td>4</td>
<td>1.685</td>
<td>0.678–4.186</td>
<td>0.261</td>
<td>R</td>
<td>0.000</td>
<td>83.5</td>
</tr>
<tr>
<td/>
<td>DD vs. II</td>
<td>4</td>
<td>2.818</td>
<td>1.431–5.551</td>
<td>0.203</td>
<td>F</td>
<td>0.026</td>
<td>72.6</td>
</tr>
<tr>
<td>KD</td>
<td>D vs. I</td>
<td>3</td>
<td>0.896</td>
<td>0.618–1.299</td>
<td>0.562</td>
<td>R</td>
<td>0.086</td>
<td>60.1</td>
</tr>
<tr>
<td/>
<td>DD + ID vs. II</td>
<td>3</td>
<td>1.181</td>
<td>0.865–1.612</td>
<td>0.294</td>
<td>F</td>
<td>0.842</td>
<td>0</td>
</tr>
<tr>
<td/>
<td>DD vs. ID + II</td>
<td>3</td>
<td>0.465</td>
<td>0.125–1.734</td>
<td>0.254</td>
<td>R</td>
<td>0.001</td>
<td>85.0</td>
</tr>
<tr>
<td/>
<td>DD vs. II</td>
<td>4</td>
<td>0.627</td>
<td>0.216–1.820</td>
<td>0.390</td>
<td>R</td>
<td>0.026</td>
<td>72.6</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1470320311434240">
<p>ACE I/D: angiotensin-converting enzyme insertion and deletion, BD: Behçet’s disease, HSP: Henoch–Schonlein purpura, KD: Kawasaki disease, OR: odds ratio, CI: confidence interval, F: fixed effects model, R: random effects model.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="fig1-1470320311434240" position="float">
<label>Figure 1.</label>
<caption>
<p>ORs and 95% CIs of individual studies and pooled data for the association between the DD + ID genotype of the ACE I/D polymorphism and vasculitis.</p>
</caption>
<graphic xlink:href="10.1177_1470320311434240-fig1.tif"/>
</fig>
</sec>
<sec id="section9-1470320311434240">
<title>Meta-analysis of the association between the <italic>ACE</italic> I/D polymorphism and BD, HSP and KD</title>
<p>The overall OR for the D allele was significantly higher in BD (OR 1.313, 95% CI 1.017–1.695, <italic>p</italic> = 0.037) (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>, <xref ref-type="fig" rid="fig2-1470320311434240">Figure 2</xref>). Meta-analysis of the DD+ID genotype, the DD genotype, and the DD vs. II genotype showed a marginal associations with BD (OR 1.428, 95% CI 0.929–2.219, <italic>p</italic> = 0.104; OR 1.371, 95% CI 0.940–2.000, <italic>p</italic> = 0.101; OR 1.624, 95% CI 0.979–2.693, <italic>p</italic> = 0.060, respectively) (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>). On the other hand, meta-analysis of the D allele and of the DD+ID genotype showed significant associations with HSP (OR 1.446, 95% CI 1.021–2.049, <italic>p</italic> = 0.038; OR 1.881, 95% CI 1.385–2.595, <italic>p</italic> = 6.6 × 10<sup>−5</sup>), whereas no such relation was found for the DD genotype or the DD vs. II genotype (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>, <xref ref-type="fig" rid="fig2-1470320311434240">Figure 2</xref>). Meta-analysis of the D allele, the DD+ID genotype, the DD genotype, and the DD vs. II genotype showed no association between KD and the <italic>ACE</italic> I/D polymorphism (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>).</p>
<fig id="fig2-1470320311434240" position="float">
<label>Figure 2.</label>
<caption>
<p>ORs and 95% CI of individual studies and pooled data for the association between the D allele of the ACE I/D polymorphism and BD and HSP.</p>
</caption>
<graphic xlink:href="10.1177_1470320311434240-fig2.tif"/>
</fig>
</sec>
<sec id="section10-1470320311434240">
<title>Heterogeneity and publication bias</title>
<p>The distributions of genotypes of the <italic>ACE</italic> I/D polymorphism in control groups were consistent with the H–W equilibrium in nine of the 12 studies. Deviation from the H–W equilibrium among controls suggests the possibility of bias during control selection or genotyping errors. When we excluded these three studies,<sup><xref ref-type="bibr" rid="bibr7-1470320311434240">7</xref>–<xref ref-type="bibr" rid="bibr9-1470320311434240">9</xref></sup> overall results of D vs. I in vasculitis were substantially affected (OR 1.276, 95% CI 1.008–1.515, <italic>p</italic> = 0.041). Between-study heterogeneity was found during meta-analyses of vasculitis, HSP, and KD, but no evidence of heterogeneity was found for meta-analyses in BD (<xref ref-type="table" rid="table2-1470320311434240">Table 2</xref>). Publication bias causes a disproportionate number of positive studies, and poses a problem for meta-analyses, but Egger’s regression test showed no evidence of publication bias in this meta-analysis of the ACE I/D polymorphism in any of the diseases studied (Egger’s regression test <italic>p</italic>-values &gt;0.1).</p>
</sec></sec>
<sec id="section11-1470320311434240" sec-type="discussion">
<title>Discussion</title>
<p>ACE is expressed in a wide range of tissues including those of the kidneys, heart, lungs, vascular endothelium, and testes. ACE plays an important role in RAS and angiotensin II conversion, increases vascular smooth muscle cell contraction, and affects smooth muscle proliferation, monocyte adhesion, platelet adhesion, and aggregation. Angiotensin II also acts as a potent pro-inflammatory modulator.<sup><xref ref-type="bibr" rid="bibr3-1470320311434240">3</xref>,<xref ref-type="bibr" rid="bibr25-1470320311434240">25</xref></sup> The <italic>ACE</italic> I/D polymorphism is located in an intron of the <italic>ACE</italic> gene, and is in strong linkage disequilibrium with genetic factors that influence serum ACE levels.<sup><xref ref-type="bibr" rid="bibr4-1470320311434240">4</xref></sup> In fact, the <italic>ACE</italic> I/D polymorphism accounts for approximately one-half of the variance in ACE plasma levels in man. Furthermore, the polymorphism has been studied in several diseases, such as Alzheimer’s disease, myocardial infarction, cerebral infarct, hypertension, and diabetic nephropathy, and these studies also reported associations between susceptibilities to these diseases and the DD genotype and D allele.<sup><xref ref-type="bibr" rid="bibr26-1470320311434240">26</xref>–<xref ref-type="bibr" rid="bibr30-1470320311434240">30</xref></sup></p>
<p>In this meta-analysis, we combined evidence on the associations between the <italic>ACE</italic> I/D polymorphism and susceptibility to BD, HSP, and KD. Furthermore, meta-analysis showed that the DD + ID genotype (dominant effect) of the <italic>ACE</italic> I/D polymorphism was associated with susceptibility to vasculitis (OR 1.468, 95% CI 1.214–1.468, <italic>p</italic> = 7.4 × 10<sup>−5</sup>). Stratification by disease type revealed a significant association between BD, HSP, and the <italic>ACE</italic> I/D polymorphism. Furthermore, the overall OR of the D allele was significantly higher in BD and HSP than in controls (OR 1.313, 95% CI 1.017–1.695, <italic>p</italic> = 0.037; OR 1.446, 95% CI 1.021–2.049, <italic>p</italic> = 0.038).</p>
<p>BD is a chronic inflammatory disease characterized by recurrent oral and genital ulcers, skin lesions, and uveitis.<sup><xref ref-type="bibr" rid="bibr31-1470320311434240">31</xref></sup> BD also affects all types and sizes of blood vessels, the joints, the central nervous system, the lungs, and the gastrointestinal system.<sup><xref ref-type="bibr" rid="bibr32-1470320311434240">32</xref></sup> Vasculitis and thrombosis are prominent features in BD and endothelial dysfunction is considered to play an important role in the pathogenesis of vasculitis in BD.<sup><xref ref-type="bibr" rid="bibr31-1470320311434240">31</xref></sup> HSP, the most common vasculitis of childhood, is a systemic vasculitis involving small vessels and affecting the skin, joints, gastrointestinal tract, and kidneys.<sup><xref ref-type="bibr" rid="bibr33-1470320311434240">33</xref></sup> Although the etiologies of BD and HSP remain unclear, it is believed that genetic and environmental factors play significant roles in their developments. RAS play an important role in the modulation of vascular tone, and ACE plays a key role in regulating RAS activity.<sup><xref ref-type="bibr" rid="bibr3-1470320311434240">3</xref></sup> Moreover, in view of the fact that the <italic>ACE</italic> I/D polymorphism accounts for approximately one-half of the variance in ACE plasma levels,<sup><xref ref-type="bibr" rid="bibr4-1470320311434240">4</xref></sup> it is likely that the <italic>ACE</italic> I/D polymorphism plays a role in susceptibility to vasculitis.</p>
<p>KD is a systemic vasculitis characterized by medium-sized arteries and coronary arthritis, and results in cardiac events, such as, ischemia and myocardial infarction.<sup><xref ref-type="bibr" rid="bibr34-1470320311434240">34</xref></sup> KD is differentiated from other vasculitis diseases based on clinical manifestations. In the present study, we found no association between KD and the <italic>ACE</italic> I/D polymorphism. We do not know exactly why the association results from KD and other vasculitis diseases were different. However, the difference may be due to small sample sizes or a different type of vasculitis. Relatively few studies were conducted on the association between KD and the <italic>ACE</italic> I/D polymorphism, and their results were heterogeneous. Further studies are required on this topic.</p>
<p>The present study has some limitations that should be considered. First, publication bias, heterogeneity, and confounding factors may have distorted the meta-analysis. Second, we were unable to perform ethnic-specific meta-analysis due to limited data. Thus, further studies are required to allow meta-analysis by ethnic group to clarify the role of the <italic>ACE</italic> I/D polymorphism in various ethnic populations. Third, the degree of vasculitis is very different in each disease and it was unclear how the degree of vasculitis was involved in each disease. It would have been interesting to have examined whether an association exists between the <italic>ACE</italic> I/D polymorphism and the activity or clinical features of vasculitides, but this was not possible in the present study due to limited data.</p>
</sec>
<sec id="section12-1470320311434240" sec-type="conclusions">
<title>Conclusion</title>
<p>This meta-analysis of the association between the ACE I/D polymorphism and vasculitis, based on a total sample of 1184 vasculitis and 1464 controls, shows that the ACE I/D polymorphism is associated with vasculitis susceptibility, especially in BD and HSP. Accordingly, our findings support the notion that the <italic>ACE</italic> I/D polymorphism plays a role in the pathogenesis of vasculitides, such as, BD and HSP.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
<fn fn-type="conflict">
<p>None.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320311434240">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bloch</surname><given-names>DA</given-names></name>
<name><surname>Michel</surname><given-names>BA</given-names></name>
<name><surname>Hunder</surname><given-names>GG</given-names></name>
<name><surname>McShane</surname><given-names>DJ</given-names></name>
<name><surname>Arend</surname><given-names>WP</given-names></name>
<name><surname>Calabrese</surname><given-names>LH</given-names></name><etal/>
</person-group>. <article-title>The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods</article-title>. <source>Arthritis Rheum</source> <year>1990</year>; <volume>33</volume>: <fpage>1068</fpage>–<lpage>1073</lpage>.</citation>
</ref>
<ref id="bibr2-1470320311434240">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Henrion</surname><given-names>D</given-names></name>
<name><surname>Benessiano</surname><given-names>J</given-names></name>
<name><surname>Levy</surname><given-names>BI</given-names></name>
</person-group>. <article-title>In vitro modulation of a resistance artery diameter by the tissue renin–angiotensin system of a large donor artery</article-title>. <source>Circ Res</source> <year>1997</year>; <volume>80</volume>: <fpage>189</fpage>–<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr3-1470320311434240">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kranzhofer</surname><given-names>R</given-names></name>
<name><surname>Schmidt</surname><given-names>J</given-names></name>
<name><surname>Pfeiffer</surname><given-names>CA</given-names></name>
<name><surname>Hagl</surname><given-names>S</given-names></name>
<name><surname>Libby</surname><given-names>P</given-names></name>
<name><surname>Kubler</surname><given-names>W</given-names></name>
</person-group>. <article-title>Angiotensin induces inflammatory activation of human vascular smooth muscle cells</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <year>1999</year>; <volume>19</volume>: <fpage>1623</fpage>–<lpage>1629</lpage>.</citation>
</ref>
<ref id="bibr4-1470320311434240">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rigat</surname><given-names>B</given-names></name>
<name><surname>Hubert</surname><given-names>C</given-names></name>
<name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name>
<name><surname>Cambien</surname><given-names>F</given-names></name>
<name><surname>Corvol</surname><given-names>P</given-names></name>
<name><surname>Soubrier</surname><given-names>F</given-names></name>
</person-group>. <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title>. <source>J Clin Invest</source> <year>1990</year>; <volume>86</volume>: <fpage>1343</fpage>–<lpage>1346</lpage>.</citation>
</ref>
<ref id="bibr5-1470320311434240">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liu</surname><given-names>D</given-names></name>
<name><surname>Lu</surname><given-names>F</given-names></name>
<name><surname>Zhai</surname><given-names>S</given-names></name>
<name><surname>Wei</surname><given-names>L</given-names></name>
<name><surname>Ma</surname><given-names>S</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name><etal/>
</person-group>. <article-title>Renin–angiotensin system gene polymorphisms in children with Henoch–Schonlein purpura in West China</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2010</year>; <volume>11</volume>: <fpage>248</fpage>–<lpage>255</lpage>.</citation>
</ref>
<ref id="bibr6-1470320311434240">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dursun</surname><given-names>A</given-names></name>
<name><surname>Durakbasi-Dursun</surname><given-names>HG</given-names></name>
<name><surname>Dursun</surname><given-names>R</given-names></name>
<name><surname>Baris</surname><given-names>S</given-names></name>
<name><surname>Akduman</surname><given-names>L</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene and endothelial nitric oxide synthase gene polymorphisms in Behcet’s disease with or without ocular involvement</article-title>. <source>Inflamm Res</source> <year>2009</year>.</citation>
</ref>
<ref id="bibr7-1470320311434240">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shim</surname><given-names>YH</given-names></name>
<name><surname>Kim</surname><given-names>HS</given-names></name>
<name><surname>Sohn</surname><given-names>S</given-names></name>
<name><surname>Hong</surname><given-names>YM</given-names></name>
</person-group>. <article-title>Insertion/deletion polymorphism of angiotensin converting enzyme gene in Kawasaki disease</article-title>. <source>J Korean Med Sci</source> <year>2006</year>; <volume>21</volume>: <fpage>208</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr8-1470320311434240">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ozkaya</surname><given-names>O</given-names></name>
<name><surname>Soylemezoglu</surname><given-names>O</given-names></name>
<name><surname>Gonen</surname><given-names>S</given-names></name>
<name><surname>Misirlioglu</surname><given-names>M</given-names></name>
<name><surname>Tuncer</surname><given-names>S</given-names></name>
<name><surname>Kalman</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Renin–angiotensin system gene polymorphisms: association with susceptibility to Henoch–Schonlein purpura and renal involvement</article-title>. <source>Clin Rheumatol</source> <year>2006</year>; <volume>25</volume>: <fpage>861</fpage>–<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr9-1470320311434240">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Turgut</surname><given-names>S</given-names></name>
<name><surname>Turgut</surname><given-names>G</given-names></name>
<name><surname>Atalay</surname><given-names>EO</given-names></name>
<name><surname>Atalay</surname><given-names>A</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme I/D polymorphism in Behcet’s disease</article-title>. <source>Med Princ Pract</source> <year>2005</year>; <volume>14</volume>: <fpage>213</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr10-1470320311434240">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ozturk</surname><given-names>MA</given-names></name>
<name><surname>Calguneri</surname><given-names>M</given-names></name>
<name><surname>Kiraz</surname><given-names>S</given-names></name>
<name><surname>Ertenli</surname><given-names>I</given-names></name>
<name><surname>Onat</surname><given-names>AM</given-names></name>
<name><surname>Ureten</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Angiotensin-converting enzyme gene polymorphism in Behcet’s disease</article-title>. <source>Clin Rheumatol</source> <year>2004</year>; <volume>23</volume>: <fpage>142</fpage>–<lpage>146</lpage>.</citation>
</ref>
<ref id="bibr11-1470320311434240">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chang</surname><given-names>HK</given-names></name>
<name><surname>Kim</surname><given-names>JU</given-names></name>
<name><surname>Lee</surname><given-names>SS</given-names></name>
<name><surname>Yoo</surname><given-names>DH</given-names></name>
</person-group>. <article-title>Lack of association between angiotensin converting enzyme gene polymorphism and Korean Behcet’s disease</article-title>. <source>Ann Rheum Dis</source> <year>2004</year>; <volume>63</volume>: <fpage>106</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr12-1470320311434240">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fukazawa</surname><given-names>R</given-names></name>
<name><surname>Sonobe</surname><given-names>T</given-names></name>
<name><surname>Hamamoto</surname><given-names>K</given-names></name>
<name><surname>Hamaoka</surname><given-names>K</given-names></name>
<name><surname>Sakata</surname><given-names>K</given-names></name>
<name><surname>Asano</surname><given-names>T</given-names></name><etal/>
</person-group>. <article-title>Possible synergic effect of angiotensin-I converting enzyme gene insertion/deletion polymorphism and angiotensin-II type-1 receptor 1166A/C gene polymorphism on ischemic heart disease in patients with Kawasaki disease</article-title>. <source>Pediatr Res</source> <year>2004</year>; <volume>56</volume>: <fpage>597</fpage>–<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr13-1470320311434240">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>SF</given-names></name>
<name><surname>Chang</surname><given-names>JS</given-names></name>
<name><surname>Peng</surname><given-names>CT</given-names></name>
<name><surname>Shi</surname><given-names>YR</given-names></name>
<name><surname>Tsai</surname><given-names>FJ</given-names></name>
</person-group>. <article-title>Polymorphism of angiotensin-1 converting enzyme gene and Kawasaki disease</article-title>. <source>Pediatr Cardiol</source> <year>2004</year>; <volume>25</volume>: <fpage>529</fpage>–<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr14-1470320311434240">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>J</given-names></name>
<name><surname>Tian</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>Q</given-names></name>
</person-group>. <article-title>Angiotensin-converting enzyme gene insertion/deletion polymorphism in children with Henoch–Schonlein purpua nephritis</article-title>. <source>J Huazhong Univ Sci Technolog Med Sci</source> <year>2004</year>; <volume>24</volume>: <fpage>158</fpage>–<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr15-1470320311434240">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murakozy</surname><given-names>G</given-names></name>
<name><surname>Gaede</surname><given-names>KI</given-names></name>
<name><surname>Ruprecht</surname><given-names>B</given-names></name>
<name><surname>Gutzeit</surname><given-names>O</given-names></name>
<name><surname>Schurmann</surname><given-names>M</given-names></name>
<name><surname>Schnabel</surname><given-names>A</given-names></name><etal/>
</person-group>. <article-title>Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener’s granulomatosis</article-title>. <source>J Mol Med (Berl)</source> <year>2001</year>; <volume>79</volume>: <fpage>665</fpage>–<lpage>670</lpage>.</citation>
</ref>
<ref id="bibr16-1470320311434240">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amoroso</surname><given-names>A</given-names></name>
<name><surname>Danek</surname><given-names>G</given-names></name>
<name><surname>Vatta</surname><given-names>S</given-names></name>
<name><surname>Crovella</surname><given-names>S</given-names></name>
<name><surname>Berrino</surname><given-names>M</given-names></name>
<name><surname>Guarrera</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch–Schoenlein patients. Italian Group of Renal Immunopathology</article-title>. <source>Nephrol Dial Transplant</source> <year>1998</year>; <volume>13</volume>: <fpage>3184</fpage>–<lpage>3188</lpage>.</citation>
</ref>
<ref id="bibr17-1470320311434240">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>YH</given-names></name>
<name><surname>Witte</surname><given-names>T</given-names></name>
<name><surname>Momot</surname><given-names>T</given-names></name>
<name><surname>Schmidt</surname><given-names>RE</given-names></name>
<name><surname>Kaufman</surname><given-names>KM</given-names></name>
<name><surname>Harley</surname><given-names>JB</given-names></name><etal/>
</person-group>. <article-title>The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case–control studies and a meta-analysis</article-title>. <source>Arthritis Rheum</source> <year>2005</year>; <volume>52</volume>: <fpage>3966</fpage>–<lpage>3974</lpage>.</citation>
</ref>
<ref id="bibr18-1470320311434240">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egger</surname><given-names>M</given-names></name>
<name><surname>Davey Smith</surname><given-names>G</given-names></name>
<name><surname>Schneider</surname><given-names>M</given-names></name>
<name><surname>Minder</surname><given-names>C</given-names></name>
</person-group>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <year>1997</year>; <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr19-1470320311434240">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Higgins</surname><given-names>JP</given-names></name>
<name><surname>Thompson</surname><given-names>SG</given-names></name>
</person-group>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source> <year>2002</year>; <volume>21</volume>: <fpage>1539</fpage>–<lpage>1558</lpage>.</citation>
</ref>
<ref id="bibr20-1470320311434240">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Egger</surname><given-names>M</given-names></name>
<name><surname>Smith</surname><given-names>GD</given-names></name>
<name><surname>Phillips</surname><given-names>AN</given-names></name>
</person-group>. <article-title>Meta-analysis: principles and procedures</article-title>. <source>BMJ</source> <year>1997</year>; <volume>315</volume>: <fpage>1533</fpage>–<lpage>1537</lpage>.</citation>
</ref>
<ref id="bibr21-1470320311434240">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>DerSimonian</surname><given-names>R</given-names></name>
<name><surname>Laird</surname><given-names>N</given-names></name>
</person-group>. <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <year>1986</year>; <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</citation>
</ref>
<ref id="bibr22-1470320311434240">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshioka</surname><given-names>T</given-names></name>
<name><surname>Xu</surname><given-names>YX</given-names></name>
<name><surname>Yoshida</surname><given-names>H</given-names></name>
<name><surname>Shiraga</surname><given-names>H</given-names></name>
<name><surname>Muraki</surname><given-names>T</given-names></name>
<name><surname>Ito</surname><given-names>K</given-names></name>
</person-group>. <article-title>Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch–Schonlein purpura nephritis</article-title>. <source>Arch Dis Child</source> <year>1998</year>; <volume>79</volume>: <fpage>394</fpage>–<lpage>399</lpage>.</citation>
</ref>
<ref id="bibr23-1470320311434240">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Takeuchi</surname><given-names>K</given-names></name>
<name><surname>Yamamoto</surname><given-names>K</given-names></name>
<name><surname>Kataoka</surname><given-names>S</given-names></name>
<name><surname>Kakihara</surname><given-names>T</given-names></name>
<name><surname>Tanaka</surname><given-names>A</given-names></name>
<name><surname>Sato</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>High incidence of angiotensin I converting enzyme genotype II in Kawasaki disease patients with coronary aneurysm</article-title>. <source>Eur J Pediatr</source> <year>1997</year>; <volume>156</volume>: <fpage>266</fpage>–<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr24-1470320311434240">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dudley</surname><given-names>J</given-names></name>
<name><surname>Afifi</surname><given-names>E</given-names></name>
<name><surname>Gardner</surname><given-names>A</given-names></name>
<name><surname>Tizard</surname><given-names>EJ</given-names></name>
<name><surname>McGraw</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Polymorphism of the ACE gene in Henoch–Schonlein purpura nephritis</article-title>. <source>Pediatr Nephrol</source> <year>2000</year>; <volume>14</volume>: <fpage>218</fpage>–<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr25-1470320311434240">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kwon</surname><given-names>CI</given-names></name>
<name><surname>Park</surname><given-names>PW</given-names></name>
<name><surname>Kang</surname><given-names>H</given-names></name>
<name><surname>Kim</surname><given-names>GI</given-names></name>
<name><surname>Cha</surname><given-names>ST</given-names></name>
<name><surname>Kim</surname><given-names>KS</given-names></name><etal/>
</person-group>. <article-title>The usefulness of angiotensin converting enzyme in the differential diagnosis of Crohn’s disease and intestinal tuberculosis</article-title>. <source>Korean J Intern Med</source> <year>2007</year>; <volume>22</volume>: <fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr26-1470320311434240">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elkins</surname><given-names>JS</given-names></name>
<name><surname>Douglas</surname><given-names>VC</given-names></name>
<name><surname>Johnston</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Alzheimer disease risk and genetic variation in ACE: a meta-analysis</article-title>. <source>Neurology</source> <year>2004</year>; <volume>62</volume>: <fpage>363</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr27-1470320311434240">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Qu</surname><given-names>H</given-names></name>
<name><surname>Lu</surname><given-names>Y</given-names></name>
<name><surname>Lin</surname><given-names>S</given-names></name>
</person-group>. <article-title>Meta-analysis on the association of ACE/ID polymorphism and essential hypertension in Chinese population</article-title>. <source>Zhonghua Yu Fang Yi Xue Za Zhi</source> <year>2001</year>; <volume>35</volume>: <fpage>408</fpage>–<lpage>411</lpage>.</citation>
</ref>
<ref id="bibr28-1470320311434240">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fujisawa</surname><given-names>T</given-names></name>
<name><surname>Ikegami</surname><given-names>H</given-names></name>
<name><surname>Kawaguchi</surname><given-names>Y</given-names></name>
<name><surname>Hamada</surname><given-names>Y</given-names></name>
<name><surname>Ueda</surname><given-names>H</given-names></name>
<name><surname>Shintani</surname><given-names>M</given-names></name><etal/>
</person-group>. <article-title>Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy</article-title>. <source>Diabetologia</source> <year>1998</year>; <volume>41</volume>: <fpage>47</fpage>–<lpage>53</lpage>.</citation>
</ref>
<ref id="bibr29-1470320311434240">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>P</given-names></name>
</person-group>. <article-title>Meta-analysis of the ACE gene in ischaemic stroke</article-title>. <source>J Neurol Neurosurg Psychiatry</source> <year>1998</year>; <volume>64</volume>: <fpage>227</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr30-1470320311434240">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Samani</surname><given-names>NJ</given-names></name>
<name><surname>Thompson</surname><given-names>JR</given-names></name>
<name><surname>O’Toole</surname><given-names>L</given-names></name>
<name><surname>Channer</surname><given-names>K</given-names></name>
<name><surname>Woods</surname><given-names>KL</given-names></name>
</person-group>. <article-title>A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction</article-title>. <source>Circulation</source> <year>1996</year>; <volume>94</volume>: <fpage>708</fpage>–<lpage>712</lpage>.</citation>
</ref>
<ref id="bibr31-1470320311434240">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakane</surname><given-names>T</given-names></name>
<name><surname>Takeno</surname><given-names>M</given-names></name>
<name><surname>Suzuki</surname><given-names>N</given-names></name>
<name><surname>Inaba</surname><given-names>G</given-names></name>
</person-group>. <article-title>Behcet’s disease</article-title>. <source>N Engl J Med</source> <year>1999</year>; <volume>341</volume>: <fpage>1284</fpage>–<lpage>1291</lpage>.</citation>
</ref>
<ref id="bibr32-1470320311434240">
<label>32.</label>
<citation citation-type="journal">
<collab>International Study Group for Behcet’s Disease</collab>. <article-title>Criteria for diagnosis of Behcet’s disease</article-title>. <source>Lancet</source> <year>1990</year>; <volume>335</volume>: <fpage>1078</fpage>–<lpage>1080</lpage>.</citation>
</ref>
<ref id="bibr33-1470320311434240">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gedalia</surname><given-names>A</given-names></name>
</person-group>. <article-title>Henoch–Schonlein purpura</article-title>. <source>Curr Rheumatol Rep</source> <year>2004</year>; <volume>6</volume>: <fpage>195</fpage>–<lpage>202</lpage>.</citation>
</ref>
<ref id="bibr34-1470320311434240">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Newburger</surname><given-names>JW</given-names></name>
<name><surname>Fulton</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Kawasaki disease</article-title>. <source>Curr Opin Pediatr</source> <year>2004</year>; <volume>16</volume>: <fpage>508</fpage>–<lpage>514</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>